Actively Recruiting

Age: 20Years +
All Genders
NCT04197414

Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

Led by Yonsei University · Updated on 2019-12-13

3000

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Urological malignancies such as prostate cancer and renal cell cancer in Korean population have been increased due to the aged population and the westernized lifestyles. With the advancement of sequencing technologies, use of genetic mutation profiles in cancer detection and progression has been increased. However, use of circulating tumor DNA in urological malignances have been limited and few studies have been reported. Therefore, we tried to evaluate the usefulness of circulating tumor DNA in detection and monitoring of urological malignancies in Korean population. This study aims to use circulating tumor DNA in plasma and urine for the diagnosis, disease progression monitoring and therapeutic response evaluation. This study plan includes building big databases for circulating tumor DNA of urological malignancies in Korean population and to develop optimized circulating tumor DNA platform.

CONDITIONS

Official Title

Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with urological malignancies including prostate cancer, renal cell cancer, bladder cancer, and ureter cancer
  • Patients who have had surgery for urological malignancies at Severance Hospital, Sinchon, between December 2019 and November 2029
  • Patients who agree to give permission for their human source information to be used
  • Patients who agree to participate in this study
Not Eligible

You will not qualify if you...

  • Patients who do not agree to participate in this study
  • Vulnerable individuals who may be susceptible to coercion, undue influence, or lack decision-making capacity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine

Seoul, South Korea, 03722

Actively Recruiting

Loading map...

Research Team

W

Won Sik Ham

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here